JP Patent

JP7651203B2 — ボロン酸誘導体およびその治療的使用

Assigned to キューペックスバイオファーマ，インコーポレイテッド · Expires 2025-03-26 · 1y expired

What this patent protects

Patent listed against Col-Probenecid.

Drugs covered by this patent

Col-Probenecid (probenecid) · Pfizer Inc.

Patent Metadata

Patent number: JP7651203B2
Jurisdiction: JP
Classification: —
Expires: 2025-03-26
Drug substance claim: No
Drug product claim: No
Assignee: キューペックスバイオファーマ，インコーポレイテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.